Litcius/Paper detail

Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab

Noemi Elisabeth Ginthör, Katharina Artinger, Marion J. Pollheimer, Martin Stradner, Kathrin Eller

2021Clinical Kidney Journal30 citationsDOIOpen Access PDF

Abstract

Immunoglobulin G4 (IgG4)-releated disease is typically associated with interstitial nephritis, but rare cases of idiopathic membranous nephropathy as a renal manifestation have been described. Obinutuzumab was successfully used in refractory membranous nephropathy, but evidence for the treatment of IgG4-related disease with obinutuzumab is lacking. We report one patient's case with membranous nephropathy associated with IgG4-related disease who was treated with obinutuzumab following an anaphylactic reaction to rituximab. Obinutuzumab treatment resulted in a sustained complete remission of membranous nephropathy and a decrease of IgG4 to the normal range. This case demonstrates that membranous nephropathy associated with IgG4-related disease can be treated successfully with obinutuzumab.

Topics & Concepts

ObinutuzumabMedicineMembranous nephropathyRituximabNephropathyChlorambucilImmunologyGastroenterologyInternal medicineAntibodyCyclophosphamideGlomerulonephritisEndocrinologyChemotherapyKidneyDiabetes mellitusIgG4-Related and Inflammatory DiseasesRenal Diseases and GlomerulopathiesGastrointestinal disorders and treatments
Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab | Litcius